Condition: Prostate Cancer · Oligometastatic Disease · Sponsor: University of Maryland, Baltimore
This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.
This description comes directly from the study's public registry record.
Zaker Rana, MD · 410-369-5200 · zaker.rana@umm.edu
Nicole Helie · 410-328-6304 · nicole.helie@umm.edu
Always discuss trial participation with your own doctor first.
| UC San Diego Moores Cancer Center | La Jolla, California, United States | Recruiting |
| KU Medical Center- Cancer Center | Kansas City, Kansas, United States | Recruiting |
| Maryland Proton Treatment Center | Baltimore, Maryland, United States | Recruiting |
| UMMC | Baltimore, Maryland, United States | Recruiting |
| Upper Chesapeake Health | Bel Air, Maryland, United States | Recruiting |
| Central Maryland Radiation Oncology | Columbia, Maryland, United States | Recruiting |
| Baltimore Washington Medical Center | Glen Burnie, Maryland, United States | Recruiting |
| Sidney Kimmel Cancer Center at Jefferson Health | Philadelphia, Pennsylvania, United States | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Bon Secours Cancer Institute at St. Francis | Midlothian, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05223803